Anti-VEGF single-domain antibody and use thereof
AssigneeShanghai Novamab Biopharmaceuticals Co., Ltd.
InventorsYakun Wan, Min Zhu, Junwei Gai, Xiaoning Shen
Life of this patent
Estimating the term…
Loading patent…
AssigneeShanghai Novamab Biopharmaceuticals Co., Ltd.
InventorsYakun Wan, Min Zhu, Junwei Gai, Xiaoning Shen
Estimating the term…
An anti-VEGF single-domain antibody and a VHH chain thereof have been described. A coding sequence for coding the single-domain antibody or the VHH chain thereof, a corresponding expression vector, a host cell capable of expressing the single-domain antibody, and a production method for the single-domain antibody have been presented. The single-domain antibody can specifically recognize human VEGFA and will not cause cross reactions with VEGFB, VEGFC and VEGFD, thus having a good specificity. The single-domain antibody can further recognize VEGFAs of a human, a rat, a rabbit and a monkey, effectively blocks interactions between VEGFA and VEGFR2 and between VEGFA and VEGFR1, has an excellent inhibiting effect on angiogenesis, and has a good stability in a non-preparation condition.
An anti-VEGF single-domain antibody, which has a VHH chain having the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.